Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:394-398
doi: 10.1161/01.CIR.0000153812.64956.EF
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kizana, E.
Right arrow Articles by Alexander, I. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kizana, E.
Right arrow Articles by Alexander, I. E.
Related Collections
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrowRelated Articles

(Circulation. 2005;111:394-398.)
© 2005 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Fibroblasts Can Be Genetically Modified to Produce Excitable Cells Capable of Electrical Coupling

Eddy Kizana, MBBS; Samantha L. Ginn, BSc, PhD; David G. Allen, MBBS, PhD; David L. Ross, MBBS, MD; Ian E. Alexander, MBBS, BMedSci, PhD

From the Department of Cardiology (E.K., D.L.R.), Westmead Hospital, Westmead; the Institute for Biomedical Research and Department of Physiology (E.K., D.G.A.), University of Sydney, Sydney; Gene Therapy Research Unit of Children’s Hospital at Westmead and Children’s Medical Research Institute (E.K., S.L.G., I.E.A.), Westmead; and the Department of Pediatrics and Child Health (I.E.A.), University of Sydney, Sydney, Australia.

Correspondence to Dr Ian E. Alexander, Gene Therapy Research Unit, Locked Bag 4001, The Children’s Hospital at Westmead, Westmead NSW, Australia 2145. E-mail iana{at}chw.edu.au

Received June 25, 2004; revision received September 13, 2004; accepted October 6, 2004.

Background— Cardiac conduction occurs in an electrical syncytium of excitable cells connected by gap junctions. Disruption of these electrophysiological properties causes conduction slowing or block. Depending on the location of affected cells within the heart, this has the potential to result in clinical syndromes such as atrioventricular block. With a view to developing gene therapy strategies for repairing cardiac conduction defects, we sought to establish whether the phenotype of fibroblasts can be modified by gene transfer to produce cells capable of electrical excitation and coupling.

Methods and Results— High-titer lentiviral vectors encoding MyoD, a myogenic transcription factor, and connexin43, a gap junction protein, were produced by established methods. Human dermal fibroblasts (HDFs) were efficiently (>80%) transduced at a multiplicity of infection of 50. HDFs transduced with the MyoD-encoding vector underwent myogenic conversion, as evidenced by myotube formation and detection of muscle-specific proteins. Importantly, calcium transients indicative of membrane excitability were observed in MyoD-induced myotubes after loading with a calcium-sensitive dye and electrical stimulation. Transients from adjacent myotubes displayed different excitation thresholds, indicating an absence of coupling between cells, consistent with skeletal muscle biology. In contrast, simultaneous transduction of HDFs with MyoD and connexin43-encoding vectors resulted in the appearance of transients in adjacent myotubes with identical thresholds, indicative of electrical coupling. Notably, dye transfer studies confirmed gap junctional intercellular communication.

Conclusions— Fibroblasts can be genetically modified to produce excitable cells capable of electrical coupling. These observations strengthen the prospect of developing gene-based strategies for repairing cardiac conduction defects.


Key Words: gene therapy • arrhythmia • conduction


Related Articles:

Issue Highlights
Circulation 2005 111: 381. [Extract] [Full Text]

Gene Therapy for Repair of Cardiac Fibrosis: A Long Way to Tipperary
Maurits Allessie, Ulrich Schotten, Sander Verheule, and Erik Harks
Circulation 2005 111: 391-393. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Physiol. Rev.Home page
M. E. Mangoni and J. Nargeot
Genesis and Regulation of the Heart Automaticity
Physiol Rev, July 1, 2008; 88(3): 919 - 982.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. Jacquemet and C. S. Henriquez
Loading effect of fibroblast-myocyte coupling on resting potential, impulse propagation, and repolarization: insights from a microstructure model
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2040 - H2052.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. Morpeth, D. Murdoch, C. H. Cabell, A. W. Karchmer, P. Pappas, D. Levine, F. Nacinovich, P. Tattevin, N. Fernandez-Hidalgo, S. Dickerman, et al.
Non-HACEK Gram-Negative Bacillus Endocarditis
Ann Intern Med, December 18, 2007; 147(12): 829 - 835.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. P. Fahrenbach, R. Mejia-Alvarez, and K. Banach
The relevance of non-excitable cells for cardiac pacemaker function
J. Physiol., December 1, 2007; 585(2): 565 - 578.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. B. Sekar, E. Kizana, R. R. Smith, A. S. Barth, Y. Zhang, E. Marban, and L. Tung
Lentiviral vector-mediated expression of GFP or Kir2.1 alters the electrophysiology of neonatal rat ventricular myocytes without inducing cytotoxicity
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2757 - H2770.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. A. Pijnappels, J. van Tuyn, A. A.F. de Vries, R. W. Grauss, A. van der Laarse, D. L. Ypey, D. E. Atsma, and M. J. Schalij
Resynchronization of Separated Rat Cardiomyocyte Fields With Genetically Modified Human Ventricular Scar Fibroblasts
Circulation, October 30, 2007; 116(18): 2018 - 2028.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. van Tuyn, D. A. Pijnappels, A. A. F. de Vries, I. de Vries, I. van der Velde-van Dijke, S. Knaan-Shanzer, A. van der Laarse, M. J. Schalij, and D. E. Atsma
Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin gene
FASEB J, October 1, 2007; 21(12): 3369 - 3379.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Cingolani, G. A. Ramirez Correa, E. Kizana, M. Murata, H. C. Cho, and E. Marban
Gene Therapy to Inhibit the Calcium Channel {beta} Subunit: Physiological Consequences and Pathophysiological Effects in Models of Cardiac Hypertrophy
Circ. Res., July 20, 2007; 101(2): 166 - 175.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. Kizana, C. Y. Chang, E. Cingolani, G. A. Ramirez-Correa, R. B. Sekar, M. R. Abraham, S. L. Ginn, L. Tung, I. E. Alexander, and E. Marban
Gene Transfer of Connexin43 Mutants Attenuates Coupling in Cardiomyocytes: Novel Basis for Modulation of Cardiac Conduction by Gene Therapy
Circ. Res., June 8, 2007; 100(11): 1597 - 1604.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
K. A. MacCannell, H. Bazzazi, L. Chilton, Y. Shibukawa, R. B. Clark, and W. R. Giles
A Mathematical Model of Electrotonic Interactions between Ventricular Myocytes and Fibroblasts
Biophys. J., June 1, 2007; 92(11): 4121 - 4132.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Allessie, U. Schotten, S. Verheule, and E. Harks
Gene Therapy for Repair of Cardiac Fibrosis: A Long Way to Tipperary
Circulation, February 1, 2005; 111(4): 391 - 393.
[Full Text] [PDF]